Compendium of Pharmaceutical Excipients for Vaginal Formulations

Garg,Sanjay;Tambwekar,Kaustubh;Vermani,Kavita;Zaneveld,Lourens;Garg,Alka;

Compendium of Pharmaceutical Excipients for Vaginal Formulations

September 1, 2001

By Sanjay Garg M Pharm, PhD
Kaustubh R. Tambwekar, PhD

News

Article

Pharmaceutical TechnologyPharmaceutical Technology-09-01-2001

Volume 2001 Supplement

Issue 3

To aid the fomulation scientist in selecting the optimal excipients for the preparation of vaginal products, the authors have compiled a list of all presently available vaginal excipients, including their functional categories and regulatory status.

External Link - article-5133.pdf

Articles in this issue

A Novel Copovidone Binder for Dry Granulation and Direct-Compression Tableting

Effects of Natural and Pregelantinized Sorghum, Plantain, and Corn Starch Binders on the Compressional Characteristics of a Paracetamol Tablet Formulation

Formulation of Acetylsalicylic Acid Tablets for Aqueous Enteric Film Coating

Evaluation of Gelatins for Cross-Linking Potential

Fast-Melting Tablets: Developments and Technologies

Compendium of Pharmaceutical Excipients for Vaginal Formulations

Related Content

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Hikma Pharmaceuticals Invests $1 Billion to Expand US Generic Drug Capabilities, Releases Sustainability Report

Susan Haigney

June 30th 2025

Article

The company is expanding its US manufacturing and R&D capabilities with a $1 billion investment by 2030.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol

April 30th 2024

Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

3D Rendering of CAR - Chimeric Antigen Receptor Between T-Cell and Cancer Cell | Image Credit: © Alpha Tauri 3D - stock.adobe.com

Priothera Awarded €1.7M in Innovation Contest for Hematologic Malignancy Treatments

Patrick Lavery

June 26th 2025

Article

The company’s mocravimod, a novel oral S1P receptor, is being evaluated for its efficacy as an addition to CAR-T cell therapies.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024

Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.